The MRPS18-2 expression was weak,and there was no differences between the groups (p = 0.26).Noteworthy, the UCKL-1 protein was expressed at higher levels in peri-tumortissues in the cases of HCC recurrence; this was confirmed for 27 olderpatients (63.78 ± 9.22 vs. 53.53 ± 4.07 years, p < 0.001),in parallel with enhanced UCKL-1 staining in former HCCnodules (62.69 ± 50.4 vs. 26.0 ± 30.19, p = 0.006)and microvascular invasion (p = 0.02). This evidence concerns the gene UCKL1 and hepatocellular carcinoma.